[HTML][HTML] The cross-talk between miRNAs and JAK/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunities

K Patil, G Sher, S Kuttikrishnan, S Moton… - Seminars in Cell & …, 2022 - Elsevier
Abstract Mycosis Fungoides (MF) and Sézary Syndrome (SS) belong to a wide spectrum of T
cell lymphoproliferative disorders collectively termed cutaneous T cell lymphomas (CTCL) …

MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas

M Gluud, A Willerslev-Olsen, LMR Gjerdrum… - Cancers, 2020 - mdpi.com
Cutaneous T-cell lymphoma (CTCL) represents a heterogeneous group of potentially
devastating primary skin malignancies. Despite decades of intense research efforts, the …

[HTML][HTML] MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma

X Shen, B Wang, K Li, L Wang, X Zhao, F Xue… - Journal of Investigative …, 2018 - Elsevier
Cutaneous T cell lymphoma (CTCL) can have clinical and histological features resembling
benign inflammatory dermatosis and can be difficult to diagnose. Very limited biomarkers …

Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment

N Rendón‐Serna, LA Correa‐Londoño… - International journal …, 2021 - Wiley Online Library
Cutaneous T‐cell lymphomas (CTCL) result from the infiltration and proliferation of a
population of T cells in the skin, inducing changes in the activity of both T cells and …

CCL21 induces mTOR-dependent MALAT1 expression, leading to cell migration in cutaneous T-cell lymphoma

CH Hong, SH Lin, CH Lee - in vivo, 2019 - iv.iiarjournals.org
Background: Mycosis fungoides (MF) is indolent, but may disseminate to leukemia. We
reported that CC motif chemokine ligand 21 (CCL21) is associated with MF invasion and …

Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoides

M Seçme, Y Dodurga, NÇ Demirkan, N Kaçar… - Gene, 2024 - Elsevier
Cutaneous T-cell lymphomas (CTCL) encompass a group of diseases characterized by the
presence of malignant clonal CD4+ T lymphocytes in the skin. Mycosis fungoides (MF) is the …

Are we there yet? cellular therapies for cutaneous T cell lymphoma

PA Atilla, E Atilla - Current Research in Translational Medicine, 2023 - Elsevier
Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of skin-involved T-cell non-
Hodgkin lymphoma which Mycosis Fungoides and Sezary Syndrome are the most common …

The role of microRNA in pathogenesis, diagnosis, different variants, treatment and prognosis of mycosis fungoides

P Wen, Y Xie, L Wang - Frontiers in Oncology, 2021 - frontiersin.org
Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL),
accounting for approximately 50% of all CTCLs. Although various molecular changes in MF …

Clinical utility of microRNA-451 as diagnostic biomarker for human cancers

Z Li, Y Li, J Fu, N Li, L Shen - Bioscience Reports, 2019 - portlandpress.com
We conducted comprehensive analyses to assess the diagnostic ability of miRNA-451 in
cancers. A systematic online search was conducted in PubMed, Web of Science, China's …

[HTML][HTML] MicroRNAs and their signaling pathway in mycosis fungoides

Z Sun, X Yao, X Ding, X Li, X Tian - Medicine, 2022 - journals.lww.com
Background: Oncogenic microRNAs, a kind of stable epigenetic inhibitors, often deregulated
in Mycosis fungoides (MF) which affect the skin and tend to transform and spread. Results …